|
|
|
BIOIDENT Technologies Inc., the leading
company in the development of printed opto-electronic solutions for life sciences, today
announced that the company is a co-winner in the semiconductor category for the
seventh annual Wall Street Journal contest for Technology Innovation. BIOIDENT was
awarded for the development of its PhotonicLab Platform™, which enables rapid in-vitro
diagnostics, chemical and biological threat detection, and environmental testing without
the need for off-site lab analysis.
“We are delighted to win this prestigious award that recognizes our innovative work on
the cutting edge of nanotechnology,” said Dr. Wasiq Bokhari, CEO for BIOIDENT. “Once
again, BIOIDENT is being acknowledged as the pioneer in applying its unique printed
opto-electronics to real-world applications. We will continue to leverage our unique
technology to develop new solutions to address major industry challenges.”
Utilizing the latest breakthroughs in science and nanotechnology, the BIOIDENT
PhotonicLab Platform is used to produce the world’s first disposable photonic lab-on-achip
solution for next-generation mobile analytics applications, such as water and food
analysis, chemical and biological agent detection, and point-of-care diagnostics. BIOIDENT
employs a process developed by its parent company, Austria's NANOIDENT Technologies
AG, for using an inkjet printer to print electronic circuits on a variety of surfaces, such as
plastic foil or glass; the technology makes it possible to apply photosensitive
semiconductors directly onto a lab-on-a-chip. The Platform eliminates the need for
complex and expensive readout systems and delivers unprecedented mobility and
sensitivity based on existing biological and chemical assays.
About The Wall Street Journal Technology Innovation Awards
As part of the 2007 award nomination process, The Wall Street Journal screened more
than 800 applications, narrowing the field to about 150 entries. A panel of 13 judges
picked category winners and runners-up in 12 different entry categories including
computing systems, energy, environment, materials and other base technologies,
media/broadcasting, medical research, medical devices, network/internet technologies, network security, semiconductors, software and transport. Each entrant was required to
offer extensive details and explain why the entry merited consideration. Judging criteria
included innovativeness, clarity of explanation, whether the innovation was covered by
patents and if it had achieved some measure of success. Factors the panel considered
included: the innovation should have gone well beyond what already existed and cannot
simply represent incremental improvements; it needed to address major challenges for
which new solutions would have a wide-ranging impact in a particular industry; the
written application needed to be supported by rigorous data rather than unsubstantiated
claims of potential.
Posted September 26th, 2007
|
